Diagnosis, Pathogenesis, and Treatment of Atrial Fibrillation
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 15 July 2024 | Viewed by 609
Special Issue Editor
Special Issue Information
Dear Colleagues,
Since atrial fibrillation (AF) is a major cause of cerebral infarction and heart failure, and the prevalence of AF increases with age, its prompt diagnosis and treatment are urgent tasks in this aging society. The management of AF remains challenging despite significant progress in understanding its underlying mechanisms.
Considerable progress has been made over the past 20 years in the treatment of AF. The evolution of therapeutic devices has been remarkable, with the advent of irrigated-tip ablation catheters, high-power short-duration techniques, and several balloon ablation catheters. These procedures are typically performed with the use of radiofrequency or cryothermal energy that heats or freezes tissue, respectively, to electrically isolate the pulmonary veins, which harbor triggers of AF. And, more recently, pulsed-field ablation has emerged. However, long-term sinus rhythm maintenance rates, although improved compared to the past, have not been as good as for the other supraventricular tachyarrhythmias. This may be due to the fact that there are still many unknowns regarding the persistent mechanisms of AF, identification of non-pulmonary vein triggers, the need for therapeutic intervention in the right as well as the left atrium, and the involvement of genetic predisposition.
We invite authors and researchers in this complex field to submit original articles and review articles relevant to this Special Issue, including studies and opinions on the pathogenesis of AF, techniques to analyze its pathogenesis, the status of disease-modifying therapies to prevent AF progression and improve outcomes, new promising therapeutic concepts, and future prospects in the field of atrial arrhythmias. We welcome your research and comments on these topics.
Dr. Kazuyoshi Suenari
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- catheter ablation
- cardiac electrophysiology
- atrial arrhythmia
